The CODEMISUSED collaboration aims to estimate and gain further understanding into the extent of codeine use, misuse and dependence in Ireland, the UK and South Africa, in order to design protective mechanisms for pharmacies to be able to track, monitor, support and refer for treatment. Given the difficulties in estimating the extent of this 'respectable form of addiction', CODEMISUSED is intended to promote the rational use of codeine products amongst the public as well as those involved in prescribing and dispensing. Ultimately the project intends to design several innovations to support and educate customers, and empower pharmacies as custodians of codeine medicines. These mechanisms could include pharmacy based brief interventions and continuing staff training.
The CODEMISUSED Project was selected for funding under the FP7 Marie Curie Industry Academia Partnership and Pathways strand and has been accepted onto the register of EC funded studies on the ENCePP register of the EMA.
To register for the Health Portal, please contact Ms. Margaret Walsh, CODEMISUSED Project Manager email@example.com
16th June 2017
31st January 2017
Dr Marie Claire Van Hout speaks to Dr. Eva Orsmond.
18th January 2017
Prof Charles Parry, Eileen Rich, Dr Marie Claire Van Hout, and Dr Paolo DeLuca
Conduct a systematic review and meta-analysis of international and national literature on prescribed, OTC and web sourced codeine use, misuse and dependence.
Develop a comparative profile of codeine product sales trends, and extent of prescribed, OTC and web sourced codeine use, misuse and dependence in Ireland, the UK and South Africa.
Identify and comparatively analyse the public health impact of therapeutic and non-therapeutic codeine use, misuse and dependence via prescribed, OTC and web-based retail sales in Ireland, the UK and South Africa.